Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update 

Go back to Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update 
GALECTIN (NASDAQ: GALT) Delayed: 4.14 +0.18 (4.55%)
Previous Close $3.96    52 Week High $3.05 
Open $4.05    52 Week Low $0.49 
Day High $4.17    P/E N/A 
Day Low $4.05    EPS $-1.32 
Volume 74,307